Europe Chronic Disease Management Market Size, Share & Industry Trends Analysis Report By Type (Solutions and Services), By End User (Healthcare Providers, Healthcare Payers and Others), By Disease Type, By Country and Growth Forecast, 2022 - 2028
The Europe Chronic Disease Management Market would witness market growth of 11.4% CAGR during the forecast period (2022-2028).
Studies that have examined how disease management programmes affect costs have generally shown evidence that the programmes decrease health care utilization, but not necessarily expenditures. For instance, Fireman et al. found that a provider-based programme run by the Permanente Medical Group of Northern California enhanced the utilization of underutilized services and enhanced physiological indicators of health, but that it did not produce overall savings due to the increased cost of the disease management programme, that included considerable efforts to alter the way primary care was delivered in addition to coaching components.
People with chronic illnesses typically need more medical services, such as doctor visits, hospital stays, and prescription medications. Health plans, the government, and employers are all looking for ways to lower health care usage expenses as a result of an escalation in the number of people who live longer with chronic health conditions and increasing health-care prices. One strategy that tries to improve care while lowering the expense of caring for the chronically ill is disease management.
The Department of Health has been the central government agency primarily in charge of establishing policies for the English healthcare and social care systems. The particular roles & responsibilities of the Department have changed as a result of the 2012 Health and Social Care Act, moving away from direct obligation for delivering the NHS to one that now offers strategic direction, serves as caretaker for the health and care system, evolves national policies, and offer guidance. NHS England, a recently formed institution, is now in charge of delivering care services and the NHS.
The Germany market dominated the Europe Chronic Disease Management Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $657.7 million by 2028.The UK market is anticipated to grow at a CAGR of 10.5% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 12.3% during (2022 - 2028).
Based on Type, the market is segmented into Solutions and Services. Based on End User, the market is segmented into Healthcare Providers, Healthcare Payers and Others. Based on Disease Type, the market is segmented into Diabetes, Cardiovascular diseases, Asthma, Chronic obstructive pulmonary disorders, Cancer and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Infosys Limited, ExlService Holdings, Inc., Health Catalyst, Inc., AllScripts Healthcare Solutions, Inc., Koninklijke Philips N.V., Cognizant Technology Solutions Corporation, Casenet, LLC, Cedar Gate Technologies, Clinical Excellence, Inc., and Altruista Health, Inc.
Scope of the Study
Market Segments covered in the Report:
By Type
- Solutions
- Services
- Healthcare Providers
- Healthcare Payers
- Others
- Diabetes
- Cardiovascular diseases
- Asthma
- Chronic obstructive pulmonary disorders
- Cancer
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Infosys Limited
- ExlService Holdings, Inc.
- Health Catalyst, Inc.
- AllScripts Healthcare Solutions, Inc.
- Koninklijke Philips N.V.
- Cognizant Technology Solutions Corporation
- Casenet, LLC
- Cedar Gate Technologies
- Clinical Excellence, Inc.
- Altruista Health, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Chronic Disease Management Market, by Type
- 1.4.2 Europe Chronic Disease Management Market, by End User
- 1.4.3 Europe Chronic Disease Management Market, by Disease Type
- 1.4.4 Europe Chronic Disease Management Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.2.4 Approvals and Trials
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
- 3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Sep – 2022, May) Leading Players
- Chapter 4. Europe Chronic Disease Management Market by Type
- 4.1 Europe Solutions Market by Country
- 4.2 Europe Services Market by Country
- Chapter 5. Europe Chronic Disease Management Market by End User
- 5.1 Europe Healthcare Providers Market by Country
- 5.2 Europe Healthcare Payers Market by Country
- 5.3 Europe Others Market by Country
- Chapter 6. Europe Chronic Disease Management Market by Disease Type
- 6.1 Europe Diabetes Market by Country
- 6.2 Europe Cardiovascular diseases Market by Country
- 6.3 Europe Asthma Market by Country
- 6.4 Europe Chronic obstructive pulmonary disorders Market by Country
- 6.5 Europe Cancer Market by Country
- 6.6 Europe Others Market by Country
- Chapter 7. Europe Chronic Disease Management Market by Country
- 7.1 Germany Chronic Disease Management Market
- 7.1.1 Germany Chronic Disease Management Market by Type
- 7.1.2 Germany Chronic Disease Management Market by End User
- 7.1.3 Germany Chronic Disease Management Market by Disease Type
- 7.2 UK Chronic Disease Management Market
- 7.2.1 UK Chronic Disease Management Market by Type
- 7.2.2 UK Chronic Disease Management Market by End User
- 7.2.3 UK Chronic Disease Management Market by Disease Type
- 7.3 France Chronic Disease Management Market
- 7.3.1 France Chronic Disease Management Market by Type
- 7.3.2 France Chronic Disease Management Market by End User
- 7.3.3 France Chronic Disease Management Market by Disease Type
- 7.4 Russia Chronic Disease Management Market
- 7.4.1 Russia Chronic Disease Management Market by Type
- 7.4.2 Russia Chronic Disease Management Market by End User
- 7.4.3 Russia Chronic Disease Management Market by Disease Type
- 7.5 Spain Chronic Disease Management Market
- 7.5.1 Spain Chronic Disease Management Market by Type
- 7.5.2 Spain Chronic Disease Management Market by End User
- 7.5.3 Spain Chronic Disease Management Market by Disease Type
- 7.6 Italy Chronic Disease Management Market
- 7.6.1 Italy Chronic Disease Management Market by Type
- 7.6.2 Italy Chronic Disease Management Market by End User
- 7.6.3 Italy Chronic Disease Management Market by Disease Type
- 7.7 Rest of Europe Chronic Disease Management Market
- 7.7.1 Rest of Europe Chronic Disease Management Market by Type
- 7.7.2 Rest of Europe Chronic Disease Management Market by End User
- 7.7.3 Rest of Europe Chronic Disease Management Market by Disease Type
- Chapter 8. Company Profiles
- 8.1 Infosys Limited
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
- 8.2 ExlService Holdings, Inc.
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expenses
- 8.2.5 Recent strategies and developments:
- 8.2.5.1 Product Launches and Product Expansions:
- 8.3 Health Catalyst, Inc.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental Analysis
- 8.3.4 Research & Development Expense
- 8.3.5 Recent strategies and developments:
- 8.3.5.1 Partnerships, Collaborations, and Agreements:
- 8.3.5.2 Product Launches and Product Expansions:
- 8.4 AllScripts Healthcare Solutions, Inc.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional & Segmental Analysis
- 8.4.4 Research & Development Expenses
- 8.5 Koninklijke Philips N.V.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expense
- 8.5.5 Recent strategies and developments:
- 8.5.5.1 Partnerships, Collaborations, and Agreements:
- 8.5.5.2 Product Launches and Product Expansions:
- 8.5.5.3 Acquisition and Mergers:
- 8.5.5.4 Approvals and Trials:
- 8.6 Cognizant Technology Solutions Corporation
- 8.6.1 Company overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 Recent strategies and developments:
- 8.6.4.1 Partnerships, Collaborations, and Agreements:
- 8.6.5 SWOT Analysis
- 8.7 Casenet, LLC (Zyter, Inc.)
- 8.7.1 Company Overview
- 8.7.2 Recent strategies and developments:
- 8.7.2.1 Product Launches and Product Expansions:
- 8.8 Cedar Gate Technologies
- 8.8.1 Company Overview
- 8.8.2 Recent strategies and developments:
- 8.8.2.1 Acquisition and Mergers:
- 8.9 Clinical Excellence, Inc.
- 8.9.1 Company Overview
- 8.10. Altruista Health, Inc. (HealthEdge Software, Inc.)
- 8.10.1 Company Overview
- 8.10.2 Recent strategies and developments:
- 8.10.2.1 Acquisition and Mergers:
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook